Healthcare M&As To Face Greater Scrutiny?

Consolidation in the healthcare industry has begun to attract the attention of anti-trust officials, journalists, and other watchdogs. With so much focus at the federal level on cutting waste and bending the long-term cost curve, officials will likely have a close eye on the line between competitive advantage and anti-competitive pricing.

Name:
E-mail:
Website:
Please enter your comment below:

Please enter the text below: